Dynamic susceptibility contrast magnetic resonance imaging in neuropsychiatry: Present utility and future promise

European Radiology

Volumn 7, Issue SUPPL. 5, 1997, Pages

  Renshaw, P F ^a   Levin, J M ^a   Kaufman, M J ^a   Ross, M H ^a   Lewis, R F ^b   Harris, G J ^b  

^a MCLEAN HOSPITAL   (United States)

^b TUFTS MEDICAL CENTER   (United States)

Author keywords

Alzheimer's disease; Dynamic susceptibility contrast magnetic resonance imaging (DSC MRI); Functional brain imaging; Functional magnetic resonance imaging (fMRI); Schizophrenia

Indexed keywords

CONTRAST MEDIUM;

BRAIN; BRAIN DISEASE; HEMODYNAMICS; HUMAN; IMAGE ENHANCEMENT; METHODOLOGY; NEUROPSYCHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; REVIEW; UTILIZATION REVIEW; VASCULARIZATION;

BRAIN; BRAIN DISEASES; CONTRAST MEDIA; HEMODYNAMIC PROCESSES; HUMANS; IMAGE ENHANCEMENT; MAGNETIC RESONANCE IMAGING; NEUROPSYCHOLOGY;

EID: 0031305928     PISSN: 09387994     EISSN: None     Source Type: Journal    
DOI: 10.1007/pl00006895     Document Type: Article

References (50)

1. Murray CJL, Lopez AD, eds (1996) The global burden of disease. Harvard Universiy Press, Cambridge, Mass
2. Villringer A, Rosen DR, Belliveau JW, Ackerman JL, Lauffer RB, Buxton RB, Chao YS, Wedeen VJ, Brady TJ (1988) Dynamic imaging with lanthanide chelates in normal brain: contrast due to magnetic susceptibility effects. Magn Reson Med 6: 164-174
3. Belliveau JW, Rosen BR, Kantor HL, Rzedzian RR, Kennedy DN, McKinstry RC, Vevea JM, Cohen MS, Pykett IL, Brady TJ (1990) Functional cerebral imaging by susceptibility-contrast NMR. Magn Reson Med 14: 538-546
4. Rosen BR, Belliveau JW, Aronen HJ, Kennedy D, Buchbinder BR, Fischman A, Gruber M, Glas J, Weisskoff RM, Cohen MS, Hochberg FH, Brady TJ (1991) Susceptibility contrast imaging of cerebral blood volume: human experience. Magn Reson Med 22: 93-299
5. Rosen BR, Belliveau JW, Chien D (1989) Perfusion imaging by nuclear magnetic resonance. Magn. Reson. Q 5: 263-281
6. Weisskoff RM, Belliveau JW, Kwong KK, Rosen BR (1993) Functional imaging of capillary hemodynamics. In: Potchen EJ, Haacke EM, Siebert JE, Gottschalk A (eds) Magnetic resonance angiography: concepts and applications. Mosby, St. Louis, pp 473-484
7. Rauch SI, Renshaw PF (1995) Clinical neuroimaging in psychiatry. Harvard Rev Psychiatry 2: 297-312
8. David A, Blamire A, Breiter H (1994) Functional magnetic resonance imaging: a new technique with implications for psychology and psychiatry [editorial]. Br J Psychiatry 164: 2-7
9. Levin JM, Ross MH, Renshaw PF (1995) Clinical applications of functional MRI in neuropsychiatry. J Neuropsychiatry Clin Neurosci 7: 511-522
10. Moonen CTW (1995) Imaging of human brain activation with functional MRI [editorial]. Biol Psychiatry 37: 141-143
11. Aronen HJ, Gazit IE, Louis DN, Buchbinder BR, Pardo FS, Weisskoff RM, Harsh GR, Cosgrove GR, Halpern EF, Hochberg FH, Rosen, BR (1994) Cerebral blood volume maps of gliomas: comparison with tumor grade and histologic findings. Radiology 191: 41-51
12. Maeda M, Itoh S, Kimura H, Iwasaki T, Hayashi N, Yamamoto K, Ishii Y, Kubota T (1994) Vascularity of meningiomas and neuromas: assessment with dynamic susceptibility-contrast MR imaging. Am J Roentgenol 163: 181-186
13. Aronen HJ, Glass J, Pardo FS, Belliveau JW, Gruber ML, Buchbinder BR, Gazit IE, Linggood RM, Fischman AJ, Rosen BR, Hochberg FH (1995) Echo-planar MR cerebral blood volume mapping of gliomas. Acta Radiol 36: 520-528
14. Edelman RR, Mattle HP, Atkinson DJ, Hill T, Finn JP, Mayman C, Ronthal M, Hoogewoud HM, Kleefield J (1990) Cerebral blood flow: assessment with dynamic contrast-enhanced T2*- weighted MR imaging at 1.5 T. Radiology 176: 211-220
15. Warach S, Li W, Ronthal M, Edelman RR (1992) Acute cerebral ischemia: evaluation with dynamic contrast-enhanced MR imaging and MR angiography. Radiology 182: 41-47
16. Warach S, Levin JM, Schomer D, Holman BL, Edelman RR (1994) Hyperperfusion of ictal seizure focus demonstrated by magnetic resonance perfusion imaging: SPECT, EEG, and clinical correlation. Am J Neuroradiol 15: 965-968
17. Masterman DL, Mendez MF, Cummings JL (1997) Sensitivity, specificity, and positive predictive value of Tc99m-HMPAO SPECT in discriminating Alzheimer's disease fromother dementias. J Geriatric Psychiatry Neurology 10: 15-22
18. Herholz K (1995) FDG PET and differential diagnosis of dementia. Alzheimer Disease and Associated Disorders 9: 6-16
19. Small GW, Mazziotta JC, Collins MT, Baxter LR, Phelps ME, Mandelkern MA, Kaplan A, La Rue A, Adamson CF, Chang L (1995) Apolipoprotein E type 4 allele and cerebral glucose metabolism in relatives at risk for familial Alzheimer disease. J Am Med Ass 273: 42-947
20. Reiman EM, Caselli RJ, Yun LS, Chen K, Bandy D, Minoshima S, Thibodeau SM, Osborne D (1996) Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E. N Eng J Medicine 334: 752-758
21. Aisen PS, Davis KL (1994) Inflammatory mechanisms in Alzheimer's disease: Implications for therapy. Am J Psychiatry 151: 1105-1113
22. Secades JJ, Frontera G (1995) CDP-choline: pharmacological and clinical review. Methods Findings Exp Clin Pharm 17 (Suppl B): 2-54
23. Muller WE, Mutschler E, Riederer P (1995) Noncompetitive NMDA receptor antagonists with fast open-channel blocking kinetics and strong voltage-dependency as potential therapeutic agents for Alzheimer's dementia. Pharmacopsychiatry 28: 113-124
24. Boller F, Orgogozo JM, Tacrine (1995) Alzheimer's disease and the cholinergic theory. A critical review. Neurologia 10: 194-199
25. Harris GJ, Lewis RF, Satlin A, English CD, Scott TM, Yurgelun-Todd DA, Renshaw PF (1996) Dynamic susceptiblity contrast MRI of regional cerebral blood volume in Alzheimer's disease. Am J Psychiatry 153: 721-724
26. Pearlson GD, Harris GJ, Powers RE, Barta PE, Camargo EE, Chase GA, Noga JR, Tune LE (1992) Quantitative chagnes in mesial temporal volume, regional cerebral blood flow, and cognition in Alzheimer's disease. Arch Gen Psychiatry 49: 402-408
27. Renshaw PF, English CD, Satlin AS, Lewis RF, Harris GJ (1996) Comparison of brain SPECT and dynamic suscpetibility contrast MR imaging in Alzheimer disease. Scientific Program of the RSNA, Paper #13, 1996
28. Johnson KA, Renshaw PF, Becker JA, Satlin A, Holman BL (1995) Comparison of functional MRI and SPECT in Alzheimer's Disease. Neurology (Suppl.) 45: 874S. (Abstract)
29. Gonzalez RG, Fischman AJ, Guimaraes AR, Carr CA, Stern CE, Halpern EF, Growdon JH, Rosen BR (1995) Functional MR in the evaluation of dementia: Correlation of abnormal dynamic cerebral blood volume measurements with changes in cerebral metabolism on positron emission tomography with fludeoxyglucose F 18. Am J Neuroradiol 16: 1763-1770
30. Maas LC, Harris GJ, Satlin A, English CD, Lewis RF, Renshaw PF (1996) Regional cerebral blood volume measured by dynamic susceptibility contrast MRI in Alzheimer's disease: a principal components analysis. J Magn Reson Imaging 7: 215-219
31. Alavi, A, Newberg A B, Souder E, Berlin JA (1993). Quantitative analysis of PET and MRI data in normal aging and Alzheimer's disease: atrophy weighted total brain metabolism and absolute whole brain metabolism as reliable discriminators. J Nucl Med 34: 1681-1687
32. American Psychiatric Association, Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, APA Press, Washington, D.C., 1994
33. Yurgelun-Todd DA, Kinney DK, Sherwood AR, Renshaw PF (1996) Magnetic resonance in schizophrenia. Semin Clin Neuropsychiatry 1: 4-19
34. Lieberman JA (1993) Understanding the mechanism of action of atypical antipsychotic drugs. A review of compounds in use and development. Br J Psychiatry 22 (Suppl): 7-18
35. Ogawa S, Lee TM, Kay AR, Tank DW (1990) Brain magnetic resonance imaging with contrast dependent on blood oxygenation. Proc Natl Acad Sci USA 87: 9868-9872
36. Kwong KK, Belliveau JW, Chesler DA, Boldberg IE, Weisskoff RM, Poncelet BP, et al (1992) Dynamic magnetic resonance imaging of human brain activity during primary sensory stimulation. Proc Natl Acad Sci USA 89: 5675-5679
37. Renshaw PF, Yurgelun TD, Cohen BM (1994) Greater hemodynamic response to photic stimulation in schizophrenic patients: an echo planar MRI study. Am J Psychiatry 151: 1493-1495
38. Taylor SF, Tandon R, Koeppe RA (1997) PET study of greater visual activation in schizophrenia. Am J Psychiatry 154: 1296-1298
39. Cohen, BM, Yurgelun-Todd D, English CD, Renshaw PF (1995) Abnormalities of regional distribution of cerebral vasculature in schizophrenia detected by dynamic susceptibility contrast MRI. Am J Psychiatry 152: 1801-1803
40. Buchsbaum MS, Potkin SG, Marshall JF, Lottenberg S, Teng C, Heh CW, Tafalla R, Reynolds C, Abel L, Pion L, et al (1992) Striatal metabolic rate and clinical response ot neuroleptics. Arch Gen Psychiatry 49: 966-974
41. Holcomb HH, Cascella NG, Thaker GK, Medoff DR, Dannals RF, Tamminga CA (1996) Functional sites of neuroleptic drug action in the human brain: PET/FDG studies with and without haloperidol. Am J Psychiatry 153: 41-49
42. Belliveau JW, Kennedy D Jr, McKinstry RC, Buchbinder BR, Weisskoff RM, Cohen MS, Vevea JM, Brady TJ, Rosen BR (1991) Functional mapping of the human visual cortex by magnetic resonance imaging. Science 254: 716-719
43. Runge VM, Kirsch JE, Wells JW, Dunworth JN, Hilaire L, Woolfolk CE (1994) Repeat cerebral blood volume assessment with first-pass MR imaging. J Magn Reson Imaging 4: 457-461
44. Levin JM, Kaufman MJ, Ross MH, Mendelson JH, Maas LC, Cohen BM, Renshaw PF (1995) Sequential dynamic susceptibility contrast MR experiments in human brain: residual contrast agent effect, steady state, and hemodynamic perturbation. Magn Reson Med 34: 655-663
45. Kaufman MJ, Levin JM, Christensen JD, Lukas SE, Mendelson JH, Maas LC, Rose SL, Cohen BM, Renshaw PF (1996) Dynamic susceptibility contrast MR measurement of cerebral blood volume reduction following intravenous cocaine administration in human subjects. In Proceedings of the 4th Annual Meeting of the International Society for Magnetic Resonance in Medicine, New York, pp. 448 (abstract)
46. Ross MH, Yurgelun-Todd DA, Renshaw PF, Maas LC, Mendelson JH, Mello NK, Cohen BM, Levin JM (1997) Age-related reduction in functional MRI response to photic stimulation. Neurology 48: 173-176
47. Levin JM, Ross MH, Mendelson JH, Mello NK, Cohen BM, Renshaw PF (1996) Gender differences in BOLD response to photic stimulation. In Proceedings of the 4th Annual Meeting of the International Society for Magnetic Resonance in Medicine, p 278. New York (abstract)
48. Mattay VS, Weinberger DR, Barrios FA, Sobering GS, Kotrla KJ, van Gelderen P, Duyn JH, Sexton RH, Moonen CT, Frank JA (1995) Brain mapping with functional MR imaging: comparison of gradient-echo- -based exogenous and endogenous contrast techniques. Radiology 194: 687-691
49. Leonard BE (1996) New approaches to the treatment of depression. J Clin Psychiatry 57 (Suppl 4): 26-33
50. Nemeroff CB (1994) Evolutionary trends in the pharmacotherapeutic management of depression. J Clin Psychiatry 55 (Suppl 12): 3-15